These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4167515)

  • 1. Multiple transmissible drug resistance in an outbreak of Shigella flexneri infection.
    Lewis MJ
    Lancet; 1967 Nov; 2(7523):953-6. PubMed ID: 4167515
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India.
    Niyogi SK; Mitra U; Dutta P
    Jpn J Infect Dis; 2001 Jun; 54(3):121-2. PubMed ID: 11544405
    [No Abstract]   [Full Text] [Related]  

  • 3. Serogroup prevalence of Shigellae in Bombay.
    Sonawala M; Saraswathi K; Deodhar LP
    J Postgrad Med; 1995; 41(4):104-6. PubMed ID: 10707731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella serotypes among hospitalized patients in urban Bangladesh and their antimicrobial resistance.
    Khan AI; Huq S; Malek MA; Hossain MI; Talukder KA; Faruque AS; Salam MA; Sack DA
    Epidemiol Infect; 2004 Aug; 132(4):773-7. PubMed ID: 15310182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferable multiple drug resistance in enterobacteria from non-human primates. I. Development and characteristics of resistance in Shigella Flexneri.
    Hardy PH; Lindsey JR; Melby EC
    Johns Hopkins Med J; 1968 Jul; 123(1):29-37. PubMed ID: 5667656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the degree of sensitivity to antibiotics of Shigella isolated from patients with dysentery in a city infectious disease hospital over the past 8 years].
    Givental' NI; Saparov OS; Bogdanova LF; Chekrygina ON; Vel'mina EA
    Antibiot Khimioter; 1988 Feb; 33(2):135-7. PubMed ID: 3288150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy.
    Cheasty T; Day M; Threlfall EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of isolation of shigella serogroups/serotypes and their antimicrobial susceptibility pattern in children from slum areas in Karachi.
    Zafar A; Sabir N; Bhutta ZA
    J Pak Med Assoc; 2005 May; 55(5):184-8. PubMed ID: 15960281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the treatment of dysentery].
    Ribiczey P; Beke G
    Orv Hetil; 1974 Mar; 115(12):677-9. PubMed ID: 4361059
    [No Abstract]   [Full Text] [Related]  

  • 13. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 14. [Shigellosis in Tananarive (Madagascar). II : Bacteriologic and therapeutic features (author's transl)].
    Capdeville P; Dion P; Pecarrere JL; Valmary J; Coignard A; Boudon A; Delprat J
    Med Trop (Mars); 1979; 39(4):453-6. PubMed ID: 395407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shigella serotypes and drug resistance patterns of strains isolated in Etimesgut, Turkey, in 1987].
    Korten V; Mert A; Ovünç K; Ceyhan M; Acar S; Ulaş T
    Mikrobiyol Bul; 1988 Apr; 22(2):89-94. PubMed ID: 3078794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistant shigellosis in south India.
    Paniker CK; Vimala KN; Bhat P; Stephen S
    Indian J Med Res; 1978 Sep; 68():413-7. PubMed ID: 744630
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-drug-resistant Shigella infections in Fujian Province, China.
    Ye XL; Cao YX; Xu JS; Wu KY; Shi XY
    J Diarrhoeal Dis Res; 1990 Sep; 8(3):99. PubMed ID: 2243184
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiresistant Shigella species isolated from childhood diarrhea cases in Kolkata, India.
    Niyogi SK; Pazhani GP
    Jpn J Infect Dis; 2003 Feb; 56(1):33-4. PubMed ID: 12711826
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotics in the management of shigellosis.
    Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.